Finance

Lists
Why is 4588 down 7,03%?
Dive Deeper
4588:TYO
Oncolys Biopharma Inc
6 350,00 JPY
-7,03%
(-480,00) 1D
7 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4588...
Open
6 750 JPY
High
6 790 JPY
Low
6 290 JPY
Mkt. cap
178,14 მლრ.
Avg. vol.
1,93 მლნ.
Volume
1,72 მლნ.
52-wk high
6 850 JPY
52-wk low
668 JPY
EPS
-54 JPY
Shares outstanding
13,14 მლნ.
No. of employees
45
Open
6 750 JPY
High
6 790 JPY
Low
6 290 JPY
Mkt. cap
178,14 მლრ.
Avg. vol.
1,93 მლნ.
Volume
1,72 მლნ.
52-wk high
6 850 JPY
52-wk low
668 JPY
EPS
-54 JPY
Shares outstanding
13,14 მლნ.
No. of employees
45
News stories
From web sources and news partners
About Oncolys Biopharma Inc
CEO-
Employees45
Founded18 მარ. 2004
Headquarters-
Sector-
Websiteoncolys.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
ივნ. 2025
სექ. 2025
მარ. 2026
ივნ. 2026
Revenue
28,55 მლნ.
-
3,09 მლნ.
500,00 მლნ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
510,47 მლნ.
303,94 მლნ.
423,81 მლნ.
846,89 მლნ.
Operating expense
511,47 მლნ.
305,01 მლნ.
423,81 მლნ.
849,46 მლნ.
Total operating expenses
511,47 მლნ.
305,01 მლნ.
423,81 მლნ.
849,46 მლნ.
Operating income
-482,92 მლნ.
-305,01 მლნ.
-420,72 მლნ.
-349,46 მლნ.
Other non operating income
13,00 ათ.
-8,69 მლნ.
-2,14 მლნ.
-62,00 ათ.
EBT including unusual items
-500,86 მლნ.
-302,92 მლნ.
-413,36 მლნ.
-347,24 მლნ.
EBT excluding unusual items
-500,86 მლნ.
-302,92 მლნ.
-413,36 მლნ.
-347,24 მლნ.
Income tax expense
713,00 ათ.
891,00 ათ.
1,12 მლნ.
430,00 ათ.
Effective tax rate
-0,14%
-0,29%
-0,27%
-0,12%
Other operating expenses
-
-
-
-
Net income
-501,58 მლნ.
-303,81 მლნ.
-414,48 მლნ.
-347,67 მლნ.
Net profit margin
-1 757,08%
-
-13 413,66%
-69,53%
Earnings per share
-
-
-
-
Interest and investment income
479,00 ათ.
1,52 მლნ.
3,04 მლნ.
199,00 ათ.
Interest expense
-1,20 მლნ.
-1,51 მლნ.
-2,99 მლნ.
-5,85 მლნ.
Net interest expenses
-725,00 ათ.
10,00 ათ.
58,00 ათ.
-5,65 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-482,90 მლნ.
-304,80 მლნ.
-420,71 მლნ.
-349,42 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები